Piazza vs TheRareLens

Piazza is the leading social learning platform for higher education, used by hundreds of thousands of students and more than 15 thousand professors for centralized class communications and polling. If you're a student, the Piazza app lets you ask and answer questions in all your Piazza classes from your mobile device, and updates you in real time when your peers are engaged. If you're an instructor, the app gives you a simple way to check in on your students during those spare moments between meetings. Stay connected to your class with Piazza!

RareLens: Research Equity for Rare Diseases The Problem Over 7,000 rare and autoimmune diseases exist but fewer than 5% have an approved treatment. Research funding from the NIH often doesn't reflect how many people a disease affects or how severely it impacts their lives. Patients wait years for a diagnosis. Researchers don't know where the biggest gaps are. Advocates don't have the data to make their case. RareLens changes that. Who It's For — Patients and caregivers who want to understand where their disease stands in the research landscape — Scientists and clinicians looking for high-impact, underserved areas to direct their work — Patient advocates building the case for more funding — Students and researchers exploring rare disease epidemiology and health equity How It Works RareLens pulls live data from NIH Reporter, PubMed, and ClinicalTrials.gov to score every disease across two dimensions: • Research Score: how much NIH funding and published science exists for a disease • Patient Burden Score: how prevalent the disease is and how severely it affects quality of life The difference between the two is the Gap Score a single number that tells you exactly how underfunded a disease is relative to the burden it places on patients. Features — Live gap scores and funding trends for rare and autoimmune diseases — Disease profiles with NIH funding history, active clinical trials, and recent publications — Year-over-year funding change tracker to catch emerging shifts in research investment — Bookmark and track the diseases that matter to you — Search any disease, even one not in our catalog and get a full score within seconds The Science Behind It Every score is formula-based, sourced from public government data, and fully reproducible. RareLens was built on a peer-reviewed methodology grounded in NIH Reporter, Orphanet prevalence data, and the Global Burden of Disease Study 2021. This is not a curated list. This is a live, data-driven map of where science is and isn't showing up for patients.